Research Overview: PHARMADRO E 200 Pharmacom
PHARMADRO E 200 is a high-grade drostanolone enanthate preparation manufactured by Pharmacom Labs, designed exclusively for scientific investigation and laboratory analysis. Drostanolone enanthate is a long-acting ester variant of drostanolone, a synthetic anabolic-androgenic steroid derived from dihydrotestosterone. This compound exhibits unique structural modifications that researchers examine for its distinct pharmacological profile in controlled laboratory environments. The enanthate ester attachment significantly extends the compound’s duration of action in research models, making it valuable for extended study protocols examining androgenic receptor interactions and tissue-selective effects.
Research scientists at Stroid UK Shop can investigate this compound’s molecular behaviour alongside other research chemicals available in our SARMs collection and peptides range. The PHARMADRO E 200 formulation provides researchers with a standardised analytical reference for examining drostanolone enanthate’s binding affinity characteristics and metabolic pathways in laboratory settings.
Scientific Applications
Drostanolone enanthate serves as an important research tool for investigating androgen receptor selectivity and tissue-specific responses in experimental models. Laboratory studies examine how the compound’s unique 2α-methyl modification affects its interaction with steroid hormone-binding globulin and aromatase enzyme systems. Research applications focus on comparative analysis of ester kinetics, examining how the enanthate ester influences pharmacokinetic parameters in various biological matrices. Scientists utilise this compound to study androgenic potency relationships and investigate the molecular mechanisms underlying tissue-selective androgenic activity patterns.
The compound’s resistance to aromatisation makes it particularly valuable for research examining non-estrogenic androgenic pathways. Investigators analyse its effects on protein synthesis markers, nitrogen retention parameters, and cellular signalling cascades in muscle tissue models. Research teams also examine the compound’s interaction with other drostanolone preparations to understand structure-activity relationships within this chemical class.
Technical Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Drostanolone Enanthate |
| Concentration | 200mg/ml |
| Manufacturer | Pharmacom Labs |
| Chemical Formula | C₂₇H₄₄O₃ |
| Molecular Weight | 416.64 g/mol |
| CAS Number | Verify with supplier |
| Storage Requirements | Room temperature, dry conditions |
| Research Form | Injectable solution |
Research Compliance Statement
PHARMADRO E 200 Pharmacom is manufactured exclusively for in-vitro research and laboratory analytical purposes. This product is not intended for human consumption, therapeutic use, or any clinical applications. Researchers must ensure appropriate laboratory safety protocols and regulatory compliance when handling this research chemical. All investigations should be conducted by qualified personnel in controlled laboratory environments with proper analytical equipment and safety measures. This compound is supplied for legitimate scientific research only.
